# Efficacy of an Oral Immunomodulatory Nutrient on Survival During Postoperative Concomitant Chemoradiotherapy in Head and Neck Cancer

> **NCT04001543** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Institut du Cancer de Montpellier - Val d'Aurelle** · enrollment: 27 (actual)

## Conditions studied

- Head and Neck Squamous Cell Carcinoma

## Interventions

- **DIETARY_SUPPLEMENT:** Immunomodulating oral supplementation
- **DIETARY_SUPPLEMENT:** Sip feed control

## Key facts

- **NCT ID:** NCT04001543
- **Lead sponsor:** Institut du Cancer de Montpellier - Val d'Aurelle
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-03-14
- **Primary completion:** 2021-03-02
- **Final completion:** 2026-05
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2025-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04001543

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04001543, "Efficacy of an Oral Immunomodulatory Nutrient on Survival During Postoperative Concomitant Chemoradiotherapy in Head and Neck Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04001543. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*